Breast cancer cells with mutations in the BRCA1 and BRCA2 genes can display defects in DSBs repair in HRR pathway and inhibition of PARP1 (poly(ADP-ribose) polymerase 1), which is a crucial protein in SSBR, can result in death of these cells [110]. Here, PARP1 is linked to breast carcinoma.